I. Sekigawa

发表

Possible role of DNA hypomethylation in the induction of SLE: relationship to the transcription of human endogenous retroviruses.

H. Hashimoto, H. Ogasawara, M. Okada, 2003, Clinical and experimental rheumatology.

DNA methylation in systemic lupus erythematosus

H. Hashimoto, H. Ogasawara, M. Okada, 2003, Lupus.

Qantitative comparison of human endogenous retrovirus mRNA between SLE and rheumatoid arthritis

H. Hashimoto, H. Ogasawara, M. Okada, 2001 .

Connective tissue growth factor promotes articular damage by increased osteoclastogenesis in patients with rheumatoid arthritis

K. Miyazawa, K. Iwabuchi, Y. Takasaki, 2009, Arthritis research & therapy.

Inhibition of the insulin-like growth factor system is a potential therapy for rheumatoid arthritis

K. Miyazawa, Y. Takasaki, H. Ogawa, 2015, Autoimmunity.

Antiribonuclease H2 antibodies are an immune biomarker for systemic lupus erythematosus

Y. Takasaki, K. Yamaji, N. Tamura, 2017, Autoimmunity.

A re-evaluation of anti-NA-14 antibodies in patients with primary Sjögren’s syndrome: Significant role of interferon-γ in the production of autoantibodies against NA-14

Y. Takasaki, E. Chan, K. Takamori, 2016, Autoimmunity.

Antibodies to microtubule-associated protein-2 in the cerebrospinal fluid are a useful diagnostic biomarker for neuropsychiatric systemic lupus erythematosus

Y. Takasaki, I. Sekigawa, K. Doe, 2016, Modern rheumatology.

Autoantibody to NA14 is an independent marker primarily for Sjogren's syndrome.

Y. Takasaki, E. Chan, T. Yen, 2009, Frontiers in bioscience.

Systemic lupus erythematosus-like autoimmune abnormalities induced by bacterial infection.

H. Hashimoto, T. Yoshiike, I. Sekigawa, 2003, Clinical and experimental rheumatology.

Allergic disorders in systemic lupus erythematosus: prevalence and family history

H. Hashimoto, T. Yoshiike, I. Sekigawa, 2002, Lupus.

Possible Role of DNA Methylation in the Induction of Systemic Lupus Erythematosus

Y. Takasaki, H. Hashimoto, M. Kawasaki, 2007 .

DNA methylation: its contribution to systemic lupus erythematosus

Y. Takasaki, M. Kawasaki, H. Ogasawara, 2006, Clinical and Experimental Medicine.

Aortic Aneurysm as a Complication of Granulomatosis with Polyangiitis Successfully Treated with Prednisolone and Cyclophosphamide: A Case Report and Review of the Literature

I. Sekigawa, K. Ikeda, T. Hirai, 2018, Case reports in rheumatology.

MicroRNA-766-3p Contributes to Anti-Inflammatory Responses through the Indirect Inhibition of NF-κB Signaling

H. Tsushima, K. Takamori, M. Kawasaki, 2019, International journal of molecular sciences.

Mizoribine Synchronized Methotrexate Therapy should be Considered when Treating Rheumatoid Arthritis Patients with an Inadequate Response to Various Combination Therapies

Y. Takasaki, K. Takamori, I. Sekigawa, 2017, Internal medicine.

Rapid onset of small intestinal perforation after successful steroid treatment in eosinophilic granulomatosis with polyangiitis

Y. Takasaki, I. Sekigawa, K. Ikeda, 2016, Modern rheumatology.

Quantitative analyses of messenger RNA of human endogenous retrovirus in patients with systemic lupus erythematosus.

H. Hashimoto, Y. Kaneko, H. Ogasawara, 2001, The Journal of rheumatology.

JAK inhibitor has the amelioration effect in lupus-prone mice: the involvement of IFN signature gene downregulation

N. Tamura, H. Tsushima, K. Takamori, 2017, BMC Immunology.

Bortezomib treatment prevents glomerulosclerosis associated with lupus nephritis in a murine model through suppressive effects on the immune and renin–angiotensin systems

Y. Takasaki, I. Sekigawa, K. Nozawa, 2017, Modern rheumatology.

CC motif chemokine ligand 13 is associated with rheumatoid arthritis pathogenesis

Y. Takasaki, K. Takamori, M. Kawasaki, 2013, Modern rheumatology.

Possible mechanisms of gender bias in SLE: a new hypothesis involving a comparison of SLE with atopy

H. Hashimoto, K. Mitsuishi, H. Ogasawara, 2004, Lupus.

HLA-DP+ T cells and deficient interleukin-2 production in patients with systemic lupus erythematosus.

H. Hashimoto, M. Abe, S. Hirose, 1990, Clinical immunology and immunopathology.

B cell hyperresponsiveness to interleukin 2 and the age-associated decline in murine lupus.

H. Sato, S. Hirose, I. Sekigawa, 1989, Clinical immunology and immunopathology.

Immunoregulatory role of IL-35 in T cells of patients with rheumatoid arthritis.

Y. Takasaki, H. Tsushima, I. Sekigawa, 2015, Rheumatology.

Interleukin-16 in patients with alopecia areata.

K. Hira, K. Mitsuishi, I. Sekigawa, 2005, Journal of dermatological science.

Subsets of activated T cells in patients with systemic lupus erythematosus: the relation to cell cycle.

H. Hashimoto, M. Abe, S. Hirose, 1997, Scandinavian journal of rheumatology.

Circulating interleukin-16 in systemic lupus erythematosus.

H. Hashimoto, H. Kaneko, I. Sekigawa, 1998, British journal of rheumatology.

A new hypothesis of the possible mechanisms of gender differences in systemic lupus erythematosus.

Y. Takasaki, M. Kawasaki, I. Sekigawa, 2010, Clinical and experimental rheumatology.

Possible importance of immunoglobulin E in foetal loss by mothers with anti‐SSA antibody

H. Hashimoto, I. Sekigawa, N. Iida, 2004, Scandinavian journal of rheumatology.

Circulating levels of beta-chemokines in systemic lupus erythematosus.

H. Hashimoto, H. Kaneko, S. Hirose, 1999, The Journal of rheumatology.

The effectiveness of new triple combination therapy using synthetic disease-modifying anti-rheumatic drugs with different pharmacological function against rheumatoid arthritis: the verification by an in vitro and clinical study

Y. Takasaki, N. Tamura, H. Tsushima, 2016, Clinical Rheumatology.

HLA-DP-positive T cells in patients with systemic lupus erythematosus.

H. Hashimoto, T. Hirose, S. Hirose, 1990, Autoimmunity.

Regenerating gene (REG) 1 alpha promotes pannus progression in patients with rheumatoid arthritis

K. Miyazawa, K. Iwabuchi, Y. Takasaki, 2012, Modern rheumatology.

Role of curdlan sulfate in the production of ,-chemokines and interleukin-16

H. Hashimoto, Y. Kaneko, H. Kaneko, 1998, Medical Microbiology and Immunology.

Differences of HIV envelope protein between HIV-1 and HIV-2: possible relation to the lower virulence of HIV-2.

H. Hashimoto, Y. Kaneko, S. Hirose, 1998, Viral immunology.

Immune Abnormalities Induced by Human Endogenous Retroviral Peptides: With Reference to the Pathogenesis of Systemic Lupus Erythematosus

H. Hashimoto, H. Ogasawara, H. Kaneko, 2003, Journal of Clinical Immunology.

Antiphospholipid antibody-associated haemophagocytic syndrome.

H. Hashimoto, M. Koike, S. Hirose, 2000, Rheumatology.

Two cases of reactive hemophagocytic syndrome: a patient with adult-onset Still's disease and a patient with herpes zoster and autoimmune abnormalities

H. Hashimoto, M. Koike, I. Sekigawa, 2001, Modern rheumatology.

Changes of CD4/CD8 Ratio and Interleukin-16 in Systemic Lupus Erythematosus

H. Hashimoto, S. Hirose, I. Sekigawa, 2000, Clinical Rheumatology.

Relationship between CD4+/CD8+ T cell ratio and T cell activation in systemic lupus erythematosus.

H. Hashimoto, S. Hirose, N. Maeda, 1999, Scandinavian journal of rheumatology.

Low-Dose Cyclosporin for Multiple Colonic Ulcers Associated with Mixed Connective Tissue Disease

H. Hashimoto, S. Hirose, N. Maeda, 1999, Clinical Rheumatology.

Effective treatment of autoimmune diseases with extremely low dose cyclosporine.

H. Hashimoto, S. Hirose, I. Sekigawa, 1998, Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology.

Effect of extremely low dose cyclosporine treatment on the thrombocytopenia in systemic lupus erythematosus

H. Hashimoto, S. Hirose, H. Ogasawara, 1998, Lupus.

Relationship between CD4(+)/CD8(+) T cell ratio and T cell activation in multiple myeloma: reference to IL-16.

H. Hashimoto, K. Oshimi, M. Koike, 2002, Leukemia research.

Two cases of dermatomyositis associated with interstitial pneumonia: a comprehensive study of gene expression.

Y. Takasaki, M. Kawasaki, H. Kaneko, 2008, Clinical and experimental rheumatology.

Expression of DNMT-1 in patients with atopic dermatitis

Toshinobu Nakamura, K. Hira, K. Mitsuishi, 2006, Archives of Dermatological Research.

Novel clinical manifestations associated with antiphospholipid antibodies.

H. Hashimoto, I. Sekigawa, N. Iida, 2000, Rheumatology.

Kinase inhibitors of the IGF-1R as a potential therapeutic agent for rheumatoid arthritis

Y. Takasaki, K. Yamaji, N. Tamura, 2017, Autoimmunity.

Social defeat stress exacerbates atopic dermatitis through downregulation of DNA methyltransferase 1 and upregulation of C-C motif chemokine receptor 7 in skin dendritic cells.

Yoshifumi Watanabe, H. Tsushima, K. Takamori, 2020, Biochemical and biophysical research communications.

A Case of Thrombotic Thrombocytopenia Purpura Associated with Systemic Lupus Erythematosus: Diagnostic Utility of ADAMTS-13 Activity

Y. Takasaki, K. Takamori, I. Sekigawa, 2011, Autoimmune diseases.

Letter to the Editor: Effect of Curdlan Sulfate on the Production of β-Chemokines and Cytokines

H. Hashimoto, Y. Kaneko, S. Hirose, 1998 .

Role of Curdlan Sulfate in the Binding of HIV‐1 gp120 to CD4 Molecules and the Production of gp120‐Mediated TNF‐α

Y. Kaneko, H. Hashimoto, S. Hirose, 1997, Microbiology and immunology.

T cells bearing unique membrane antigen and their regulatory role in humoral immune response in mice

H. Sato, T. Shirai, W. Yumura, 1986, European journal of immunology.

Generalized pustular psoriasis‐like eruptions induced after the first use of adalimumab in the treatment of psoriatic arthritis

K. Takamori, Y. Suga, I. Sekigawa, 2012, The Journal of dermatology.

Characterization of autoantibodies to the CD4 molecule in human immunodeficiency virus infection.

K. Takatsuki, R. Byrn, I. Sekigawa, 1991, Clinical immunology and immunopathology.

Class-specific Regulation of Anti-DNA Antibody Synthesis in (NZB×NZW) F1 Hybrid Mice

I. Sekigawa, 1987 .

Requirement of H‐2 heterozygosity for autoimmunity in (NZB × NZW)F1 hybrid mice

S. Hirose, I. Sekigawa, T. Shirai, 1986, European journal of immunology.

Soluble interleukin-2 receptor in sera of patients with systemic lupus erythematosus

H. Hashimoto, S. Hirose, I. Sekigawa, 1988 .

Inhibition of rheumatoid arthritis by blocking connective tissue growth factor.

Y. Takasaki, I. Sekigawa, K. Nozawa, 2014, World journal of orthopedics.

[Effect of HIV envelope glycoprotein on the induction of immune dysregulation in HIV infection].

H. Kaneko, I. Sekigawa, H. Akimoto, 1998, Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology.

Human immunodeficiency virus type 2 envelope glycoprotein binds to CD8 as well as to CD4 molecules on human T cells

H. Nakauchi, H. Hashimoto, Y. Kaneko, 1997, Journal of virology.

The possible role of interleukin-16 in the low incidence of HIV infection in patients with systemic lupus erythematosus

H. Hashimoto, Y. Kaneko, S. Hirose, 2000, Lupus.

Role of tumour necrosis factor‐alpha (TNF‐α) in the induction of HIV‐1 gp120‐mediated CD4+ T cell anergy

H. Hashimoto, Y. Kaneko, H. Kaneko, 1997, Clinical and experimental immunology.

Ulcerative colitis associated with autoimmune progesterone dermatitis.

H. Hashimoto, S. Hirose, I. Sekigawa, 1997, Journal of clinical gastroenterology.

Syncytial cell formation in vivo by type C retroviral particles in the systemic lupus erythematosus (SLE) lung

H. Hashimoto, S. Kira, I. Sekigawa, 1997, Clinical and experimental immunology.

Pseudolymphoma of the liver associated with Sjögren's syndrome.

H. Hashimoto, I. Sekigawa, N. Iida, 2001, Scandinavian journal of rheumatology.

Molecular mimicry between human endogenous retrovirus clone 4-1 and HLA class I antigen with reference to the pathogenesis of systemic lupus erythematosus.

H. Hashimoto, Y. Kaneko, S. Hirose, 1999, Rheumatology.

Detection of antibodies to HIV-1 gp41- and HLA class II antigen-derived peptides in SLE patients.

H. Hashimoto, T. Hishikawa, I. Sekigawa, 1995, Scandinavian journal of rheumatology.

Genetic and cellular basis of anti-DNA antibody synthesis in systemic lupus erythematosus of New Zealand mice.

H. Sato, S. Hirose, I. Sekigawa, 1987, The Journal of rheumatology. Supplement.

Inhibitory effect of the immunosuppressant FK506 on apoptotic cell death induced by HIV-1 gp120

Y. Takasaki, H. Hashimoto, S. Hirose, 1995, Journal of Clinical Immunology.

Detection of antibodies to a recombinant gag protein derived from human endogenous retrovirus clone 4-1 in autoimmune diseases.

H. Hashimoto, T. Shirasawa, Y. Matsuura, 1997, Viral immunology.

Synchronous malignant B-cell lymphoma and gastric tubular adenocarcinoma associated with paraneoplastic cutaneous vasculitis: hypereosinophilic syndrome with mixed cryoglobulinemia is an important sign of paraneoplastic syndrome

Y. Takasaki, K. Takamori, F. Suzuki, 2009, Rare tumors.

Cytomegalovirus infection in patients with systemic lupus erythematosus.

H. Hashimoto, I. Sekigawa, N. Iida, 2002, Clinical and experimental rheumatology.

Possible role of the JAK/STAT pathways in the regulation of T cell-interferon related genes in systemic lupus erythematosus

Y. Takasaki, K. Takamori, M. Kawasaki, 2011, Lupus.

Estrogen inhibits apoptosis and promotes CC motif chemokine ligand 13 expression on synovial fibroblasts in rheumatoid arthritis

Y. Takasaki, K. Takamori, M. Kawasaki, 2012, Immunopharmacology and immunotoxicology.

Cellular basis of in vitro anti-DNA antibody production: evidence for T cell dependence of IgG-class anti-DNA antibody synthesis in the (NZB X NZW)F1 hybrid.

H. Sato, S. Hirose, I. Sekigawa, 1986, Journal of immunology.

A case of hypopituitarism associated with antiphospholipid syndrome.

H. Hashimoto, I. Sekigawa, N. Iida, 2000, Rheumatology.

[A case of hypopituitarism and primary hypothyroidism associated with antiphospholipid syndrome].

H. Hashimoto, I. Sekigawa, N. Iida, 2000, Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology.

Chemoattractant mechanism of Th1 cells in class III and IV lupus nephritis

Y. Takasaki, H. Kaneko, I. Sekigawa, 2009, Autoimmunity.

H. Hashimoto, H. Ogasawara, M. Okada, 2002, The Journal of infection.

REVIEW ARTICLE Lessons from Similarities between SLE and HIV Infection

H. Hashimoto, H. Ogasawara, M. Okada, 2002 .

Retroviruses and autoimmunity.

Ogasawara, H. Hashimoto, H. Ogasawara, 2001, Internal medicine.

Analysis of Human Immunodeficiency Virus Type 1 Integration by Using A Specific, Sensitive and Quantitative Assay Based on Real-time Polymerase Chain Reaction

T. Naito, Yasunori Saito, N. Yamamoto, 2006, Virus Genes.

Characterization of in vitro inhibition of human immunodeficiency virus by purified recombinant CD4

J. Groopman, D. Capon, S. Chamow, 1989, Journal of virology.

CD4 immunoadhesin, but not recombinant soluble CD4, blocks syncytium formation by human immunodeficiency virus type 2-infected lymphoid cells

J. Groopman, S. Chamow, R. Byrn, 1990, Journal of virology.

Antibody against chromatin assembly factor-1 is a novel autoantibody specifically recognized in systemic lupus erythematosus

K. Takamori, M. Kawasaki, H. Amano, 2014, Lupus.

Role of DNA methylation in transcription of human endogenous retrovirus in the pathogenesis of systemic lupus erythematosus.

H. Hashimoto, Y. Kaneko, H. Ogasawara, 2002, The Journal of rheumatology.

lupus erythematosus Possible role of the JAK / STAT pathways in the regulation of T cell-interferon related genes in systemic

Y. Takasaki, K. Takamori, M. Kawasaki, 2011 .

Systemic lupus erythematosus and human endogenous retroviruses

H. Hashimoto, H. Ogasawara, H. Kaneko, 2003, Modern rheumatology.

Allergic diseases in systemic lupus erythematosus: prevalence and immunological considerations.

H. Hashimoto, T. Yoshiike, I. Sekigawa, 2003, Clinical and experimental rheumatology.

A Possible Pathogenic Role of CD8+ T Cells and their Derived Cytokine, IL-16, in SLE

H. Hashimoto, N. Maeda, H. Kaneko, 2001, Autoimmunity.

Exacerbation of systemic lupus erythematosus related to cytomegalovirus infection

Y. Tomino, H. Hashimoto, S. Hirose, 1998, Lupus.

Possible triggering effect of cytomegalovirus infection on systemic lupus erythematosus.

H. Hashimoto, I. Sekigawa, M. Nawata, 2001, Scandinavian journal of rheumatology.

Cyclosporin A therapy for interstitial pneumonitis associated with rheumatic disease

H. Hashimoto, H. Kaneko, N. Tamura, 2002, Modern rheumatology.

Thrombocytopenia in systemic lupus erythematosus associated with cytomegalovirus infection.

H. Hashimoto, S. Hirose, T. Hishikawa, 1997, Scandinavian journal of rheumatology.

Comparison of serum IgE levels between female and male SLE patients, with reference to gender differences in the incidence of SLE.

H. Hashimoto, I. Sekigawa, N. Iida, 2004, Clinical and experimental rheumatology.

HIV infection and SLE: their pathogenic relationship.

H. Hashimoto, Y. Kaneko, S. Hirose, 1998, Clinical and experimental rheumatology.

The production of &bgr;‐chemokines induced by HIV‐2 envelope glycoprotein

H. Hashimoto, Y. Kaneko, S. Hirose, 1997, AIDS.

Class-specific regulation of anti-DNA antibody synthesis and the age-associated changes in (NZB x NZW)F1 hybrid mice.

H. Sato, S. Hirose, I. Sekigawa, 1987, Journal of immunology.

Haemophagocytic syndrome in a systemic lupus erythematosus patient with antiphospholipid antibodies.

H. Hashimoto, K. Oshimi, M. Koike, 2001, Rheumatology.

Securely collecting multidimensional health information from patients with rheumatoid arthritis using smart device technology: Beneficial effect for physicians and patients

K. Yamaji, N. Tamura, K. Takamori, 2018, Musculoskeletal care.

Estrogen receptor expression by peripheral blood mononuclear cells of patients with systemic lupus erythematosus

Hideoki Ogawa, Akihiro Inui, Y. Takasaki, 2007, Clinical Rheumatology.

Protein biomarker analysis by mass spectrometry in patients with rheumatoid arthritis receiving anti-tumor necrosis factor-alpha antibody therapy.

Y. Takasaki, S. Sone, K. Takamori, 2008, Clinical and experimental rheumatology.

Circulating plasma microRNA profiling in patients with polymyositis/dermatomyositis before and after treatment: miRNA may be associated with polymyositis/dermatomyositis

Y. Takasaki, K. Yamaji, N. Tamura, 2018, Inflammation and Regeneration.

Cyclosporine treatment of advanced interstitial pneumonitis associated with systemic sclerosis

Y. Takasaki, H. Hashimoto, I. Sekigawa, 1999 .

Two cases of atopic dermatitis associated with autoimmune abnormalities.

H. Hashimoto, T. Yoshiike, I. Sekigawa, 2003, Rheumatology.

JAK inhibitor has the amelioration effect in lupus-prone mice: the involvement of IFN signature gene downregulation

N. Tamura, H. Tsushima, K. Takamori, 2017, BMC Immunology.

Fluctuations in the gene expression of peripheral blood mononuclear cells between the active and inactive phases of systemic lupus erythematosus.

Y. Takasaki, K. Takamori, M. Kawasaki, 2010, Clinical and experimental rheumatology.

Changes in the gene expression of peripheral blood mononuclear cells during the menstrual cycle of females is associated with a gender bias in the incidence of systemic lupus erythematosus.

Y. Takasaki, K. Takamori, M. Kawasaki, 2009, Clinical and experimental rheumatology.

Hemophagocytosis in autoimmune disease.

H. Hashimoto, K. Oshimi, M. Koike, 2001, Clinical and experimental rheumatology.

Inhibition of connective tissue growth factor ameliorates disease in a murine model of rheumatoid arthritis.

K. Iwabuchi, Y. Takasaki, K. Takamori, 2013, Arthritis and rheumatism.

Nodular regenerative hyperplasia of the liver in systemic lupus erythematosus. The relationship with anticardiolipin antibody and lupus anticoagulant.

H. Hashimoto, S. Hirose, T. Hishikawa, 1997, Scandinavian journal of rheumatology.

Genetic regulation of hypergammaglobulinaemia and the correlation to autoimmune traits in (NZB X NZW) F1 hybrid.

H. Sato, S. Hirose, I. Sekigawa, 1984, Clinical and experimental immunology.

Circulating plasma microRNA profiling in patients with polymyositis/dermatomyositis before and after treatment: miRNA may be associated with polymyositis/dermatomyositis

Y. Takasaki, K. Yamaji, N. Tamura, 2018, Inflammation and regeneration.

Successful treatment with adalimumab in a patient with psoriatic arthritis and generalized pustular psoriasis

K. Takamori, Y. Suga, I. Sekigawa, 2012, The Journal of dermatology.

Intestinal perforation due to hemorrhagic Cytomegalovirus enteritis in a patient with severe uncontrolled lupus nephritis: a case and review of the literature

N. Tamura, S. Tomita, I. Sekigawa, 2017, Rheumatology International.

INTERLEUKIN-16 IN SYSTEMIC LUPUS ERYTHEMATOSUS

H. Hashimoto, H. Kaneko, I. Sekigawa, 1998 .

Detection of serum IgE class anti-SSA antibodies in mothers with foetal loss

Y. Takasaki, K. Takamori, H. Kaneko, 2008, Rheumatology International.

A possible novel mechanism of opportunistic infection in systemic lupus erythematosus, based on a case of toxoplasmic encephalopathy.

H. Hashimoto, K. Mori, M. Maeda, 2002, Rheumatology.

Connective Tissue Growth Factor Neutralization Aggravates the Psoriasis Skin Lesion: The Analysis of Psoriasis Model Mice and Patients

H. Tsushima, K. Takamori, Y. Suga, 2017, Annals of dermatology.

Inhibition of each module of connective tissue growth factor as a potential therapeutic target for rheumatoid arthritis

K. Miyazawa, Y. Takasaki, K. Takamori, 2016, Autoimmunity.

The detection of plasma levels of connective tissue growth factor in rheumatoid arthritis patients.

Y. Takasaki, K. Takamori, M. Kawasaki, 2012, Clinical and experimental rheumatology.

Serum Proteome Analysis in Patients with Rheumatoid Arthritis Receiving Therapy with Tocilizumab: An Anti-Interleukin-6 Receptor Antibody

Y. Takasaki, K. Takamori, M. Yanagida, 2013, BioMed research international.

Serum proteome analysis in patients with rheumatoid arthritis receiving therapy with etanercept, a chimeric tumor necrosis factor‐alpha receptor

Y. Takasaki, S. Sone, K. Takamori, 2012, International journal of rheumatic diseases.

Sequence Analysis of Human Endogenous Retrovirus Clone 4-1 in Systemic Lupus Erythematosus

H. Hashimoto, H. Ogasawara, T. Hishikawa, 2001, Autoimmunity.

Kinase inhibitors of the IGF-1R as a potential therapeutic agent for rheumatoid arthritis

Y. Takasaki, K. Yamaji, N. Tamura, 2017, Autoimmunity.

Exposure of female NZBWF1 mice to imiquimod-induced lupus nephritis at an early age via a unique mechanism that differed from spontaneous onset.

Y. Kataoka, K. Takamori, I. Sekigawa, 2022, Clinical and experimental immunology.